Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons
BOSTON, May 1, 2024 /PRNewswire/ -- Ora, Inc., the world's leading partner for ophthalmic pharmaceutical and device development, today announced its participation as a major exhibitor in the Association for Research in Vision and Ophthalmology (ARVO) 2024 conference (May 5-9), and as host and convener of the Dry Horizons Symposium (May 3) in partnership with Ophthalmology Innovation Source. Both events will take place in Seattle.
- "Team Ora is thrilled to be heading to ARVO which sets the benchmark as the premier showcase for the latest advancements in ophthalmic translational research," stated Stuart B. Abelson, President, CEO, and Chairman of Ora.
- Just two days before the start of ARVO, Ora will co-present the first-ever Dry Horizons Symposium with Ophthalmology Innovation Source.
- At ARVO, Ora will occupy booth #1630, which will feature Ora's people, processes and technologies that together increase the likelihood of success for ophthalmic research programs around the globe.
- Ora will also be exhibiting a robust slate of original research presentations at ARVO as detailed in the schedule below.